The DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer
Open accessAbstract
The RAF/MEK/ERK signaling pathway regulates diverse cellular processes as exemplified by cell proliferation, differentiation, motility, and survival. Activation of ERK1/2 generally promotes cell proliferation, and its deregulated activity is a hallmark of many cancers. Therefore, components and regulators of the ERK pathway are considered potential therapeutic targets for cancer, and inhibitors of this pathway, including some MEK and BRAF inhibitors, are already being used in the clinic. Notably, ERK1/2 kinases also have pro-apoptotic functions under certain conditions and enhanced ERK1/2 signaling can cause tumor cell death. Although the repertoire of the compounds which mediate ERK activation and apoptosis is expanding, and various anti-cancer compounds induce ERK activation while exerting their anti-proliferative effects, the mechanisms underlying ERK1/2-mediated cell death are still vague. Recent studies highlight the importance of dual-specificity phosphatases (DUSPs) in determining the pro- versus anti-apoptotic function of ERK in cancer. In this review, we will summarize the recent major findings in understanding the role of ERK in apoptosis, focusing on the major compounds mediating ERK-dependent apoptosis. Studies that further define the molecular targets of these compounds relevant to cell death will be essential to harnessing these compounds for developing effective cancer treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Han, M., Gao, H. Y., Ju, P., Gao, M., Yuan, Y., Chen, X., Liu, K.-L., Han, Y., & Han, Z. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.014 · Cited by 95
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
COSMIC: the Catalogue Of Somatic Mutations In Cancer
Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., Boutselakis, H., Cole, C. G., Creatore, C., Dawson, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1015 · Cited by 4,867
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases
Cargnello, M., & Roux, P. P. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-10 · Cited by 3,274
MAPK signal pathways in the regulation of cell proliferation in mammalian cells
ZHANG, W., & LIU, H. T. (2002) · Cell Research · doi:10.1038/sj.cr.7290105 · Cited by 2,845
Apoptosis: controlled demolition at the cellular level
Taylor, R. C., Cullen, S. P., & Martin, S. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2312 · Cited by 2,624
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
ERK1/2 MAP kinases: Structure, function, and regulation
Roskoski, R. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.04.005 · Cited by 1,650
Apoptosis in neurodegenerative disorders
Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605
ERK/MAPK signalling pathway and tumorigenesis (Review)
Guo, Y., Pan, W., Liu, S., Shen, Z., Xu, Y., & Hu, L. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8454 · Cited by 1,475
ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence
Cagnol, S., & Chambard, J. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07366.x · Cited by 1,290
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
Targeting RAS–ERK signalling in cancer: promises and challenges
Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163
Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB
Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J., & Evan, G. (1997) · Nature · doi:10.1038/385544a0 · Cited by 1,148
Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
Santarpia, L., Lippman, S. M., & El-Naggar, A. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645805 · Cited by 1,027
Dysregulation of Apoptosis in Cancer
Reed, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2941 · Cited by 987
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., Becelaere, K. V., Wiland, A., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A., Przybranowski, S., et al. (1999) · Nature Medicine · doi:10.1038/10533 · Cited by 970
The MAPK pathway across different malignancies: A new perspective
Burotto, M., Chiou, V. L., Lee, J., & Kohn, E. C. (2014) · Cancer · doi:10.1002/cncr.28864 · Cited by 956
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
Braicu, C., Buse, M., Busuioc, C., Drula, R., Gulei, D., Raduly, L., Rusu, A., Irimie, A., Atanasov, A. G., Slaby, O., et al. (2019) · Cancers · doi:10.3390/cancers11101618 · Cited by 944
Nox proteins in signal transduction
Brown, D. I., & Griendling, K. K. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.023 · Cited by 832
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways
McCubrey, J. A., LaHair, M. M., & Franklin, R. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1775 · Cited by 803
Oxidative stress and apoptosis: Impact on cancer therapy
Ozben, T. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20874 · Cited by 751
ERK implication in cell cycle regulation
Chambard, J.-C., Lefloch, R., Pouysségur, J., & Lenormand, P. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.010 · Cited by 750
Redox signaling and the MAP kinase pathways
Torres, M., & Forman, H. J. (2003) · BioFactors · doi:10.1002/biof.5520170128 · Cited by 580
Negative feedback regulation of the ERK1/2 MAPK pathway
Lake, D., Corrêa, S. A. L., & Müller, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2297-8 · Cited by 565
Stanciu, M., Wang, Y., Kentor, R., Burke, N., Watkins, S., Kress, G., Reynolds, I., Klann, E., Angiolieri, M. R., Johnson, J. W., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12200 · Cited by 539
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
Degirmenci, U., Wang, M., & Hu, J. (2020) · Cells · doi:10.3390/cells9010198 · Cited by 534
Mirza, A., McGuirk, M., Hockenberry, T. N., Wu, Q., Ashar, H., Black, S., Wen, S. F., Wang, L., Kirschmeier, P., Bishop, W. R., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205353 · Cited by 530
Tumour cell survival signalling by the ERK1/2 pathway
Balmanno, K., & Cook, S. J. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.148 · Cited by 484
The Role of PI3K/Akt and ERK in Neurodegenerative Disorders
Rai, S. N., Dilnashin, H., Birla, H., Singh, S. S., Zahra, W., Rathore, A. S., Singh, B. K., & Singh, S. P. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-0003-y · Cited by 478
Targeting Alterations in the RAF–MEK Pathway
Yaeger, R., & Corcoran, R. B. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1321 · Cited by 465
The ERK Cascade: A Prototype of MAPK Signaling
Rubinfeld, H., & Seger, R. (2005) · Molecular Biotechnology · doi:10.1385/mb:31:2:151 · Cited by 460
Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy
Liu, F., Yang, X., Geng, M., & Huang, M. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.01.008 · Cited by 432
ERK Activation Mediates Cell Cycle Arrest and Apoptosis after DNA Damage Independently of p53
Tang, D., Wu, D., Hirao, A., Lahti, J. M., Liu, L., Mazza, B., Kidd, V. J., Mak, T. W., & Ingram, A. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111598200 · Cited by 422
Reduced MAP Kinase Phosphatase-1 Degradation After p42/p44 MAPK -Dependent Phosphorylation
Brondello, J.-M., Pouysségur, J., & McKenzie, F. R. (1999) · Science · doi:10.1126/science.286.5449.2514 · Cited by 419
Targeting the ERK signaling pathway in cancer therapy
Kohno, M., & Pouyssegur, J. (2006) · Annals of Medicine · doi:10.1080/07853890600551037 · Cited by 416
Inhibition of Ras for Cancer Treatment: The Search Continues
Baines, A. T., Xu, D., & Der, C. J. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.121 · Cited by 382
A Death-Promoting Role for Extracellular Signal-Regulated Kinase
Zhuang, S., & Schnellmann, R. G. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107367 · Cited by 355
Nguyen, T. T. T. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh052 · Cited by 344
PEA-15 Mediates Cytoplasmic Sequestration of ERK MAP Kinase
Formstecher, E., Ramos, J. W., Fauquet, M., Calderwood, D. A., Hsieh, J.-C., Canton, B., Nguyen, X.-T., Barnier, J.-V., Camonis, J., Ginsberg, M. H., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00035-1 · Cited by 313
Raf: A Strategic Target for Therapeutic Development Against Cancer
Beeram, M., Patnaik, A., & Rowinsky, E. K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.036 · Cited by 298
Redox regulation of cell signalling
Lander, H. M., Milbank, A. J., Tauras, J. M., Hajjar, D. P., Hempstead, B. L., Schwartz, G. D., Kraemer, R. T., Mirza, U. A., Chait, B. T., Burk, S. C., et al. (1996) · Nature · doi:10.1038/381380a0 · Cited by 297
Ogier-Denis, E., Pattingre, S., El Benna, J., & Codogno, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006198200 · Cited by 288
Pattingre, S., Bauvy, C., & Codogno, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210998200 · Cited by 273
Oxidative neuronal injury: The dark side of ERK1/2
Chu, C. T., Levinthal, D. J., Kulich, S. M., Chalovich, E. M., & DeFranco, D. B. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04132.x · Cited by 272
Nowak, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206373200 · Cited by 265
ERK and cell death: ERK1/2 in neuronal death
Subramaniam, S., & Unsicker, K. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07367.x · Cited by 263
MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb
Kawakami, Y., Rodríguez-León, J., Koth, C. M., Büscher, D., Itoh, T., Raya, Á., Ng, J. K., Esteban, C. R., Takahashi, S., Henrique, D., et al. (2003) · Nature Cell Biology · doi:10.1038/ncb989 · Cited by 259
Liu, J., Mao, W., Ding, B., & Liang, C.-S. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00407.2008 · Cited by 255
Fehrenbacher, N., Bastholm, L., Kirkegaard-Sørensen, T., Rafn, B., Bøttzauw, T., Nielsen, C., Weber, E., Shirasawa, S., Kallunki, T., & Jäättelä, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0463 · Cited by 242
Jo, S.-K., Cho, W. Y., Sung, S. A., Kim, H. K., & Won, N. H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67102.x · Cited by 235
The influence of reactive oxygen species on cell cycle progression in mammalian cells
Verbon, E. H., Post, J. A., & Boonstra, J. (2012) · Gene · doi:10.1016/j.gene.2012.08.038 · Cited by 233
Huang, K., Chen, Y., Zhang, R., Wu, Y., Ma, Y., Fang, X., & Shen, S. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0166-5 · Cited by 231
The dual-specificity MAP kinase phosphatases: critical roles in development and cancer
Bermudez, O., Pagès, G., & Gimond, C. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00347.2009 · Cited by 230
Extrinsic and Intrinsic Apoptosis Signal Pathway Review
Hongmei, Z. (2012) · InTech eBooks · doi:10.5772/50129 · Cited by 220
Bidirectional signals transduced by DAPK–ERK interaction promote the apoptotic effect of DAPK
Chen, C., Wang, W., Kuo, J., Tsai, H., Lin, J., Chang, Z., & Chen, R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600510 · Cited by 220
Ellington, A. A., Berhow, M. A., & Singletary, K. W. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi214 · Cited by 209
Mandl, M., Slack, D. N., & Keyse, S. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.1830-1845.2005 · Cited by 206
RSK and MSK in MAP kinase signalling
Hauge, C., & Frödin, M. (2006) · Journal of Cell Science · doi:10.1242/jcs.02950 · Cited by 204
Zhang, X., Shan, P., Sasidhar, M., Chupp, G. L., Flavell, R. A., Choi, A. M. K., & Lee, P. J. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0156oc · Cited by 201
Kulich, S. M., & Chu, C. T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00304.x · Cited by 198
Ekerot, M., Stavridis, M. P., Delavaine, L., Mitchell, M. P., Staples, C., Owens, D. M., Keenan, I. D., Dickinson, R. J., Storey, K. G., & Keyse, S. M. (2008) · Biochemical Journal · doi:10.1042/bj20071512 · Cited by 195
Unni, A. M., Lockwood, W. W., Zejnullahu, K., Lee-Lin, S.-Q., & Varmus, H. (2015) · eLife · doi:10.7554/elife.06907 · Cited by 190
ERKs in cancer: friends or foes?
Deschênes-Simard, X., Kottakis, F., Meloche, S., & Ferbeyre, G. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2381 · Cited by 186
Chiarugi, P., Fiaschi, T., Taddei, M. L., Talini, D., Giannoni, E., Raugei, G., & Ramponi, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102302200 · Cited by 185
Lu, T.-H., Tseng, T.-J., Su, C.-C., Tang, F.-C., Yen, C.-C., Liu, Y.-Y., Yang, C.-Y., Wu, C.-C., Chen, K.-L., Hung, D.-Z., et al. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2013.10.013 · Cited by 184
Zhuang, S., Yan, Y., Daubert, R. A., Han, J., & Schnellmann, R. G. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00170.2006 · Cited by 167
Role of ERK activation in cisplatin‐induced apoptosis in OK renal epithelial cells
Kim, Y. K., Kim, H. J., Kwon, C. H., Kim, J. H., Woo, J. S., Jung, J. S., & Kim, J. M. (2005) · Journal of Applied Toxicology · doi:10.1002/jat.1081 · Cited by 167
Cotargeting survival signaling pathways in cancer
Grant, S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36898 · Cited by 164
Quercetin augments TRAIL-induced apoptotic death: Involvement of the ERK signal transduction pathway
Kim, Y.-H., Lee, D.-H., Jeong, J.-H., Guo, Z. S., & Lee, Y. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.02.016 · Cited by 162
Emerging Role for ERK as a Key Regulator of Neuronal Apoptosis
Cheung, E. C. C., & Slack, R. S. (2004) · Science's STKE · doi:10.1126/stke.2512004pe45 · Cited by 162
Phenotypic Characterization of a Comprehensive Set of MAPK1/ERK2 Missense Mutants
Brenan, L., Andreev, A., Cohen, O., Pantel, S., Kamburov, A., Cacchiarelli, D., Persky, N. S., Zhu, C., Bagul, M., Goetz, E. M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.061 · Cited by 160
ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway
Kidger, A. M., Sipthorp, J., & Cook, S. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.007 · Cited by 160
Oxidative stress-induced apoptosis is mediated by ERK1/2 phosphorylation
Lee, Y.-J., Cho, H.-N., Soh, J.-W., Jhon, G. J., Cho, C.-K., Chung, H.-Y., Bae, S., Lee, S.-J., & Lee, Y.-S. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00391-4 · Cited by 159
Guo, Y., Zhang, X., Meng, J., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.02.005 · Cited by 151
MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms
Wu, P., & Park, J. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.023 · Cited by 147
Zheng, A., Kallio, A., & Härkönen, P. L. (2007) · Endocrinology · doi:10.1210/en.2006-1269 · Cited by 146
Chen, J. R., Plotkin, L. I., Aguirre, J. I., Han, L., Jilka, R. L., Kousteni, S., Bellido, T., & Manolagas, S. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411530200 · Cited by 146
Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells
Tong, J., Zhang, Q., Huang, X., Fu, X., Qi, S., Wang, Y., Hou, Y., Sheng, J., & Sun, Q. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016781 · Cited by 141
Cotargeting survival signaling pathways in cancer
Grant, S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36898e1 · Cited by 141
Wang, Z.-Q., Wu, D., Huang, F., & Yang, G. (2003) · Brain Research · doi:10.1016/j.brainres.2003.09.074 · Cited by 138
Lin, Y., & Yang, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508720200 · Cited by 137
Harris, D., Bonfil, D., Chuderland, D., Kraus, S. R., Seger, R., & Naor, Z. (2002) · Endocrinology · doi:10.1210/endo.143.3.8675 · Cited by 136
Li, X., Feng, K., Li, J., Yu, D., Fan, Q., Tang, T., Yao, X., & Wang, X. (2017) · Nutrients · doi:10.3390/nu9040414 · Cited by 134
Yeh, P.-S., Wang, W., Chang, Y.-A., Lin, C., Wang, J.-J., & Chen, R. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.08.030 · Cited by 133
Karlsson, M. E., Mathers, J. E., Dickinson, R. J., Mandl, M., & Keyse, S. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406720200 · Cited by 132
Chambon, J., Soule, J. D., Pomiès, P., Fort, P., Sahuquet, A., Alexandre, D., Mangeat, P.-H., & Baghdiguian, S. (2002) · Development · doi:10.1242/dev.129.13.3105 · Cited by 132
Luttrell, L. M. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0300117 · Cited by 130
Zhang, P., Wang, Y.-Z., Kagan, E., & Bonner, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910425199 · Cited by 126
Regulatory Mechanisms and Function of ERK MAP Kinases
Torii, S. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh159 · Cited by 125
Sugiura, R., Toda, T., Shuntoh, H., Yanagida, M., & Kuno, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.140 · Cited by 122
Self-citationPark, B. G., Yoo, C. I., Kim, H. T., Kwon, C. H., & Kim, Y. K. (2005) · Toxicology · doi:10.1016/j.tox.2005.07.003 · Cited by 119
Kim, B., Lee, E.-R., Min, H.-M., Jeong, H., Ahn, J.-Y., Kim, J., Choi, H.-Y., Choi, H.-N., Kim, E. Y., Park, S. P., et al. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.7.6164 · Cited by 119
Unni, A. M., Harbourne, B., Oh, M. H., Wild, S. A., Ferrarone, J. R., Lockwood, W. W., & VARMUS, H. E. (2018) · eLife · doi:10.7554/elife.33718 · Cited by 116
Therapeutic targeting of RAS: New hope for drugging the “undruggable”
Khan, I., Rhett, J. M., & O’Bryan, J. P. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118570 · Cited by 112
Liu, Y., & Fan, D. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.07.008 · Cited by 110
Lee, E.-R., Kang, Y.-J., Kim, J., Lee, H. T., & Cho, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505537200 · Cited by 108
Park, B. H., Lim, J. E., Jeon, H. G., Seo, S. I., Lee, H. M., Choi, H. Y., Jeon, S. S., & Jeong, B. C. (2016) · Oncotarget · doi:10.18632/oncotarget.11563 · Cited by 106
Ghosh, J., Das, J., Manna, P., & Sil, P. C. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.011 · Cited by 104
Increased MAPK Activity and MKP-1 Overexpression in Human Gastric Adenocarcinoma
Bang, Y., Kwon, J. H., Kang, S. H., Kim, J. W., & Yang, Y. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9256 · Cited by 104
G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breast cancer cells
Rao, A., & Herr, D. R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.05.001 · Cited by 104
Sinha, D., Bannergee, S., Schwartz, J. H., Lieberthal, W., & Levine, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312048200 · Cited by 101
Woessmann, W., Chen, X., & Borkhardt, A. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0502-y · Cited by 101
Kidger, A. M., Rushworth, L. K., Stellzig, J., Davidson, J., Bryant, C., Bayley, C., Caddye, E., Rogers, T., Keyse, S. M., & Caunt, C. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614684114 · Cited by 101
The Role of Mitogen-Activated Protein Kinase Phosphatase-1 in Oxidative Damage–Induced Cell Death
Zhou, J.-Y., Liu, Y., & Wu, G. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4229 · Cited by 98
Ramachandiran, S., Huang, Q., Dong, J., Lau, S. S., & Monks, T. J. (2002) · Chemical Research in Toxicology · doi:10.1021/tx0200663 · Cited by 98
Activation of ERK signaling and induction of colon cancer cell death by piperlongumine
Randhawa, H., Kibble, K., Zeng, H., Moyer, M. P., & Reindl, K. M. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.04.006 · Cited by 97
Sreenivasulu, R., Reddy, K. T., Sujitha, P., Kumar, C. G., & Raju, R. R. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.02.002 · Cited by 92
The Involvement of MAPK Signaling Pathways in Determining the Cellular Response to p53 Activation
Brown, L. M., & Benchimol, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507951200 · Cited by 91
Yeh, P.-Y., Chuang, S., Yeh, K., Song, Y., Chang, L. L.-Y., & Cheng, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207426 · Cited by 90
Billecke, C., Finniss, S., Tahash, L., Miller, C. G., Mikkelsen, T., Farrell, N. P., & Bögler, O. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-004 · Cited by 90
ERK and cell death: cadmium toxicity, sustained ERK activation and cell death
Martin, P., & Pognonec, P. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07369.x · Cited by 86
Lin, M., Lin, A., Wu, D., Wang, S. S. W., Chang, F., Wu, Y., & Huang, Y. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.05.029 · Cited by 86
Yun, S., Jung, J. H., Jeong, S., Sohn, E. J., Kim, B., & Kim, S. (2013) · Phytotherapy Research · doi:10.1002/ptr.5015 · Cited by 84
Huang, F., Liu, Q., Xie, S., Xu, J., Huang, B., Wu, Y., & Xia, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060885 · Cited by 83
Comprehensive Analysis of ERK1/2 Substrates for Potential Combination Immunotherapies
Yang, L., Zheng, L., Chng, W. J., & Ding, J. L. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.09.005 · Cited by 83
Recruitment and Activation of Raf-1 Kinase by Nitric Oxide-Activated Ras
Deora, A. A., Hajjar, D. P., & Lander, H. M. (2000) · Biochemistry · doi:10.1021/bi992954b · Cited by 82
Bartholomeusz, C., Rosen, D. G., Wei, C., Kazansky, A., Yamasaki, F., Takahashi, T., Itamochi, H., Kondo, S., Liu, J., & Ueno, N. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2592 · Cited by 82
Bhartiya, D., & Singh, J. (2014) · Reproduction · doi:10.1530/rep-14-0220 · Cited by 78
Singh, S., Upadhyay, A. K., Ajay, A. K., & Bhat, M. K. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.12.035 · Cited by 77
Kong, D., Zheng, T., Zhang, M., Wang, D., Du, S., Li, X., Fang, J., & Cao, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069403 · Cited by 76
Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK
Wang, S. (2001) · Carcinogenesis · doi:10.1093/carcin/22.5.757 · Cited by 75
Dynamics and control of the ERK signaling pathway: Sensitivity, bistability, and oscillations
Arkun, Y., & Yasemi, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195513 · Cited by 75
Non-Apoptotic Cell Death Signaling Pathways in Melanoma
Hartman, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082980 · Cited by 74
Etoposide induced cytotoxicity mediated by ROS and ERK in human kidney proximal tubule cells
Shin, H., Kwon, H., Lee, J., Anwar, M. A., & Choi, S. (2016) · Scientific Reports · doi:10.1038/srep34064 · Cited by 73
Yang, R. R., Piperdi, S., & Gorlick, R. G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5113 · Cited by 72
Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cδ
Basu, A., & Tu, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.199 · Cited by 70
Tsai, M.-H., Liu, J., Chiang, Y., Hu, S. C., Hsu, L.-F., Lin, Y., Lin, Z., Lee, H.-C., Chen, M.-C., Huang, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16058 · Cited by 68
Lu, K., Liang, C., Liliang, P., Yang, C., Cho, C., Weng, H., Tsai, Y., Wang, K., & Chen, H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06747.x · Cited by 65
Choi, M., Park, H., Oh, J., Lee, E. H., Park, S., & Yoon, S. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2886 · Cited by 64
Yang, T., Chang, G., Chen, K., Hung, H., Hsu, K.-H., Sheu, G., & Hsu, S. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.057 · Cited by 64
Meng, G., Wang, W., Chai, K., YANG, S., Li, F., & JIANG, K. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2814 · Cited by 64
Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin
Wang, X., Govind, S., Sajankila, S. P., Mi, L., Roy, R., & Chung, F. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000560 · Cited by 63
Notch1 regulates endothelial apoptosis via the ERK pathway in chronic obstructive pulmonary disease
Zong, D., Li, J., Cai, S., He, S., Liu, Q., Jiang, J., Chen, S., Long, Y., Chen, Y., Chen, P., et al. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00182.2017 · Cited by 63
Tsai, S.-C., Huang, W.-W., Huang, W., Lu, C., Chiang, J., Peng, S., Chung, J., Lin, Y.-H., Hsu, Y., Amagaya, S., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1640 · Cited by 62
Mebratu, Y. A., Dickey, B. F., Evans, C., & Tesfaigzi, Y. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801186 · Cited by 61
ERK Inhibition: A New Front in the War against MAPK Pathway–Driven Cancers?
Smalley, I., & Smalley, K. S. M. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1355 · Cited by 61
U0126 Protects Cells against Oxidative Stress Independent of Its Function as a MEK Inhibitor
Ong, Q., Guo, S., Zhang, K., & Cui, B. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500288n · Cited by 60
Zhang, C., Liu, S., Yuan, X., Hu, Z., Li, H., Wu, M., Yuan, J., Zhao, Z., Su, J., Wang, X., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447912 · Cited by 60
Szydłowska, K., Góźdź, A., Dąbrowski, M., Zawadzka, M., & Kaminska, B. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06656.x · Cited by 59
Yiran, Z., Chenyang, J., Wang, J., Yan, Y., Jianhong, G., Jianchun, B., XueZhong, L., & Zong-ping, L. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/516051 · Cited by 59
Wang, Y.-F., Xu, Y.-L., Tang, Z.-H., Li, T., Zhang, L., Chen, X., Lu, J., Leung, C., Ma, D., Qiang, W., et al. (2017) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x17500094 · Cited by 59
Wang, J., Liu, X., Zheng, H., Liu, Q., Zhang, H., Wang, X., Shen, T., Wang, S., & Ren, D. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109279 · Cited by 59
Zhuang, S., Kinsey, G. R., Yan, Y., Han, J., & Schnellmann, R. G. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136358 · Cited by 58
Baek, S. H., Kim, C., Lee, J. H., Nam, D., Lee, J., Lee, S., Chung, W., Jang, H.-J., Kim, S., & Ahn, K. S. (2015) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2015.1027916 · Cited by 57
Jiao, Y., Wu, L., Xue, D., Liu, X., Tian, Z., Jiang, S., Han, S., & Li, P. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0646-4 · Cited by 57
Park, S. A., Park, H. J., Lee, B. I., Ahn, Y., Kim, S. U., & Choi, K. S. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00176-0 · Cited by 56
León‐Buitimea, A., Rodríguez‐Fragoso, L., Lauer, F. T., Bowles, H., Thompson, T. A., & Burchiel, S. W. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.12.009 · Cited by 56
Activation of c-Raf Kinase by Ultraviolet Light
Hoyos, B., Imam, A., Korichneva, I., Levi, E., Chua, R., & Hammerling, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110750200 · Cited by 55
Oliveira, M. D. S., Barbosa, M. I. F., de Souza, T. B., Moreira, D. R. M., Martins, F. T., Villarreal, W., Machado, R. P., Doriguetto, A. C., Soares, M. B. P., & Bezerra, D. P. (2019) · Redox Biology · doi:10.1016/j.redox.2018.10.006 · Cited by 55
Jo, J.-R., Park, J. S., Park, Y.-K., Chae, Y. Z., Lee, G., Park, G.-Y., & Jang, B. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1263 · Cited by 54
Snyder, A., Alsauskas, Z. C., Leventhal, J. S., Rosenstiel, P. E., Gong, P., Chan, J., Barley, K. M., He, C., Klotman, M. E., Ross, M. J., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328337b0ab · Cited by 54
Signal Transduction by MAP Kinases: Regulation by Phosphorylation-Dependent Switches
Whitmarsh, A. J., & Davis, R. J. (1999) · Science Signaling · doi:10.1126/stke.1999.1.pe1 · Cited by 54
ERK Pathway Inhibitors: How Low Should We Go?
Nissan, M. H., Rosen, N. X., & Solit, D. B. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0245 · Cited by 54
Saud, K., Herrera‐Molina, R., & Rommy von Bernhardi, M. (2005) · Neurotoxicity Research · doi:10.1007/bf03033981 · Cited by 53
Hasan, I., Sugawara, S., Fujii, Y., Koide, Y., Terada, D., Iimura, N., Fujiwara, T., TAKAHASHI, K. G., Kojima, N., Rajia, S., et al. (2015) · Marine Drugs · doi:10.3390/md13127071 · Cited by 52
Chen, J., Hsieh, M., Chen, C., Lin, J., Lo, Y., Chuang, Y., Chien, S., & Chen, M. (2016) · Oncotarget · doi:10.18632/oncotarget.11839 · Cited by 52
Activation of Ras Up-regulates Pro-apoptotic BNIP3 in Nitric Oxide-induced Cell Death
An, H., Maeng, O., Kang, K.-H., Lee, J., Kim, Y.-S., Paik, S., & Lee, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605819200 · Cited by 51
Role and regulation of MKP-1 in airway inflammation
Moosavi, S. M. S., Prabhala, P., & Ammit, A. J. (2017) · Respiratory Research · doi:10.1186/s12931-017-0637-3 · Cited by 51
Triptolide induces autophagy and apoptosis through ERK activation in human breast cancer MCF‑7 cells
Gao, H., Zhang, Y., Dong, L., Qu, X., Tao, L., Zhang, Y., Zhai, J., & Song, Y. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5830 · Cited by 51
Lee, Y. J., Lee, H.-G., & Yang, J. (2012) · Chemosphere · doi:10.1016/j.chemosphere.2012.08.033 · Cited by 50
Feedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells
Furukawa, T., Tanji, E., Xu, S., & Horii, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.003 · Cited by 49
Zhao, H., Liu, W., Wang, Y., Dai, N., Gu, J., Yuan, Y., Liu, X., Bian, J., & Liu, Z. (2015) · Journal of Veterinary Science · doi:10.4142/jvs.2015.16.3.297 · Cited by 47
Jang, H. J., Hong, E. M., Park, S. W., Byun, H. W., Koh, D. H., Choi, M. H., Kae, S. H., & Lee, J. (2016) · Oncology Letters · doi:10.3892/ol.2016.4569 · Cited by 46
Pathania, A. S., Kumar, S. G., Guru, S. K., Bhushan, S., Sharma, P. R., Aithagani, S. K., Singh, P. P., Vishwakarma, R. A., Kumar, A., & Malik, F. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110411 · Cited by 44
NMDA receptor-mediated ERK 1/2 pathway is involved in PFHxS-induced apoptosis of PC12 cells
Lee, Y. J., Choi, S.-Y., & Yang, J. (2014) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2014.01.114 · Cited by 43
Chi, J., Zhu, Y., Fu, Y., Liu, Y., Zhang, X., Han, L., Yin, X., & Zhao, D. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1336-5 · Cited by 43
Nabeyrat, E., Jones, G. E., Fenwick, P. S., Barnes, P. J., & Donnelly, L. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00178.2002 · Cited by 43
Sun, C., Li, C., Li, X., Zhu, Y., Su, Z., Wang, X., He, Q., Zheng, G., & Feng, B. (2018) · Journal of Cancer · doi:10.7150/jca.25921 · Cited by 43
Cheng, L., Xia, T., Wang, Y., Zhou, W., Liang, X.-Q., Xue, J., Shi, L., Wang, Y., & Ding, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090848 · Cited by 42
The Effect of Doxorubicin on MEK-ERK Signaling Predicts Its Efficacy in HCC
Choi, J. N., Yip-Schneider, M., Albertin, F., Wiesenauer, C. A., Wang, Y., & Schmidt, C. M. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.01.029 · Cited by 42
Arbon, K. S., Christensen, C. M., Harvey, W. A., & Heggland, S. J. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.10.031 · Cited by 42
MATSUNAGA, Y., KAWAI, Y., Kohda, Y., & Gemba, M. (2005) · The Journal of Toxicological Sciences · doi:10.2131/jts.30.135 · Cited by 42
Huang, C.-F., Liu, S., Su, C., Fang, K., Yen, C., Yang, C., Tang, F., Liu, J., Wu, C.-C., Lee, K.-I., et al. (2021) · Toxicology · doi:10.1016/j.tox.2021.152764 · Cited by 42
Rieber, M., & RIEBER, M. S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21478 · Cited by 41
Teng, H., Huang, Q., & Chen, L. (2016) · Food & Function · doi:10.1039/c6fo00715e · Cited by 41
Targeting Cancer with PCPA‐Drug Conjugates: LSD1 Inhibition‐Triggered Release of 4‐Hydroxytamoxifen
Ota, Y., Itoh, Y., Kaise, A., Ohta, K., Endo, Y., Masuda, M., Sowa, Y., Sakai, T., & Suzuki, T. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201608711 · Cited by 41
Sprouty2 enhances the tumorigenic potential of glioblastoma cells
Park, J., Wollmann, G., Urbiola, C., Fogli, B., Florio, T., Geley, S., & Klimaschewski, L. P. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy028 · Cited by 41
Shikonin inhibits proliferation of melanoma cells by MAPK pathway-mediated induction of apoptosis
Lee, J. H., Han, S. H., Kim, Y. M., Kim, S. H., Yoo, E. S., Woo, J., Jung, G.-H., Jung, S. H., Kim, B. S., & Jung, J. (2021) · Bioscience Reports · doi:10.1042/bsr20203834 · Cited by 40
Pal, P., Kanaujiya, J. K., Lochab, S., Tripathi, S. B., Bhatt, M. L. B., Singh, P. K., Sanyal, S., & Trivedi, A. K. (2011) · PROTEOMICS · doi:10.1002/pmic.201000720 · Cited by 38
Banerjee, C., Goswami, R., Datta, S., Rajagopal, R., & Mazumder, S. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.07.007 · Cited by 38
Feng, D., Wang, B., Ma, Y., Shi, W., Tao, K. X., Zeng, W., Cai, Q., Zhang, Z., & Qin, H. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9490-x · Cited by 38
Identification of an In Vivo MEK/WOX1 Complex as a Master Switch for Apoptosis in T Cell Leukemia
Lin, H.-P., Chang, J.-Y., Lin, S.-R., Lee, M.-H., Huang, S., Hsu, L., & Chang, N. (2011) · Genes & Cancer · doi:10.1177/1947601911418498 · Cited by 37
Cerioni, L., Palomba, L., & Cantoni, O. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00675-6 · Cited by 36
NLRP3 deficiency exacerbates enterovirus infection in mice
Wang, C., Fung, G., Deng, H., Jagdeo, J. M., Mohamud, Y., Xue, Y. C., Jan, E., Hirota, J. A., & Luo, H. (2018) · The FASEB Journal · doi:10.1096/fj.201800301rrr · Cited by 36
Bhattarai, G., Lee, Y., Lee, N., Lee, I., Yun, B., Hwang, P.-H., & Yi, H. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00297 · Cited by 34
Negrín, G., Eiroa, J. L., Morales, M., Triana, J., Quintana, J., & Estévez, F. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20629 · Cited by 34
ERK Signals: Scaffolding Scaffolds?
Casar, B., & Crespo, P. (2016) · Front. Cell Dev. Biol. · doi:10.3389/fcell.2016.00049 · Cited by 34
Kumari, R., V, Chouhan, S., Singh, S., Chhipa, R. R., Ajay, A. K., & Bhat, M. K. (2017) · Journal of Biosciences · doi:10.1007/s12038-017-9667-8 · Cited by 34
Ji, S., Sun, R., Xu, K., Man, Z., Ji, J., Pu, Y., Yin, L., Zhang, J., & Pu, Y. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.05.003 · Cited by 33
Pan, T., & Wang, P. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/734987 · Cited by 32
Cited by
Apoptosis in Alzheimer’s disease: Insight into the signaling pathways and therapeutic avenues
Kumari, S., Dhapola, R., & Reddy, D. H. (2023) · Apoptosis · doi:10.1007/s10495-023-01848-y · Cited by 324
The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target
Steckelings, U. M., Widdop, R. E., Sturrock, E. D., Lubbe, L., Hussain, T., Kaschina, E., Unger, T., Hallberg, A., Carey, R. M., & Sumners, C. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000281 · Cited by 97
MAPKs in the early steps of senescence implemEMTation
Anerillas, C., Altés, G., & Gorospe, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1083401 · Cited by 13
Metadata
- Authors
- Sugiura, R., Satoh, R., & Takasaki, T.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-09-22
- Volume
- 10
- Issue
- 10
- Pages
- 2509
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3199076451
- Cited by
- 369
- References
- 249
- FWCI
- 13.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.